466 related articles for article (PubMed ID: 31439642)
1.
Cheng Y; Liu J; Luan Y; Liu Z; Lai H; Zhong W; Yang Y; Yu H; Feng N; Wang H; Huang R; He Z; Yan M; Zhang F; Sun YG; Ying H; Guo F; Zhai Q
Diabetes; 2019 Nov; 68(11):2120-2130. PubMed ID: 31439642
[TBL] [Abstract][Full Text] [Related]
2. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
[TBL] [Abstract][Full Text] [Related]
4. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
[TBL] [Abstract][Full Text] [Related]
5. Sarm1 knockout prevents type 1 diabetic bone disease in females independent of neuropathy.
Brazill JM; Shen IR; Craft CS; Magee KL; Park JS; Lorenz M; Strickland A; Wee NK; Zhang X; Beeve AT; Meyer GA; Milbrandt J; DiAntonio A; Scheller EL
JCI Insight; 2024 Jan; 9(4):. PubMed ID: 38175722
[TBL] [Abstract][Full Text] [Related]
6. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy.
Turkiew E; Falconer D; Reed N; Höke A
J Peripher Nerv Syst; 2017 Sep; 22(3):162-171. PubMed ID: 28485482
[TBL] [Abstract][Full Text] [Related]
8. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
9. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
[TBL] [Abstract][Full Text] [Related]
10. SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.
Summers DW; Gibson DA; DiAntonio A; Milbrandt J
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6271-E6280. PubMed ID: 27671644
[TBL] [Abstract][Full Text] [Related]
11. Novel role of SARM1 mediated axonal degeneration in the pathogenesis of rabies.
Sundaramoorthy V; Green D; Locke K; O'Brien CM; Dearnley M; Bingham J
PLoS Pathog; 2020 Feb; 16(2):e1008343. PubMed ID: 32069324
[TBL] [Abstract][Full Text] [Related]
12. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
Ko KW; Milbrandt J; DiAntonio A
J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
[TBL] [Abstract][Full Text] [Related]
13. Macrophage depletion blocks congenital SARM1-dependent neuropathy.
Dingwall CB; Strickland A; Yum SW; Yim AK; Zhu J; Wang PL; Yamada Y; Schmidt RE; Sasaki Y; Bloom AJ; DiAntonio A; Milbrandt J
J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36287209
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy targeting SARM1 blocks pathological axon degeneration in mice.
Geisler S; Huang SX; Strickland A; Doan RA; Summers DW; Mao X; Park J; DiAntonio A; Milbrandt J
J Exp Med; 2019 Feb; 216(2):294-303. PubMed ID: 30642945
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
[TBL] [Abstract][Full Text] [Related]
17. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
18. SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration.
Chen YH; Sasaki Y; DiAntonio A; Milbrandt J
Exp Neurol; 2021 May; 339():113636. PubMed ID: 33548217
[TBL] [Abstract][Full Text] [Related]
19. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
[TBL] [Abstract][Full Text] [Related]
20. Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.
Viar K; Njoku D; Secor McVoy J; Oh U
PLoS One; 2020; 15(6):e0235110. PubMed ID: 32584865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]